CATAGEN LIMITED

Company number NI603059 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

1. Risk Rating: HIGH

Justification: While the company is technically solvent with a strong equity position of £6.78 million, it exhibits severe liquidity stress. Cash reserves have depleted to just £10,385, working capital is negative at (£885,388), and short-term bank debt has surged to over £2.1 million. This combination, alongside a 25% drop in turnover, presents a high immediate financial risk despite the underlying asset strength.

2. Key Concerns

  1. Acute Liquidity Squeeze: The company's cash position fell from £238,629 in May 2024 to a critically low £10,385 in May 2025. Current liabilities (£5.01 million) now exceed current assets (£4.13 million), resulting in negative working capital. The company appears to be heavily relying on short-term bank loans and overdrafts (£2.10 million due within one year) to fund daily operations.
  2. Revenue Decline: Turnover dropped by 25% year-on-year, falling from £6.05 million to £4.54 million. While the company still reported an operating profit, this was heavily bolstered by £3.83 million in "other operating income." A sustained decline in core revenue could exacerbate the existing cash flow pressures.
  3. Director Loan Governance: The accounts reveal unsecured, interest-free loans to directors (name shown to subscribers: £149,997; Prof. Roy name shown to subscribers: £8,841; name shown to subscribers: £14,377) with no specified repayment dates. While properly disclosed, extending interest-free credit to directors while the company faces severe liquidity constraints and pays £407,040 in interest on its own borrowings raises governance and capital allocation questions.

3. Positive Indicators

  1. Strong Asset Base and Solvency: The company has total net assets of £6.78 million, more than doubling from £3.11 million in the prior year. It holds £12.41 million in fixed assets, indicating significant capital investment in tangible assets (plant and machinery) and intangible assets.
  2. Profitability and Tax Efficiency: The company reported a profit for the year of £2.57 million. This was supported by a £1.26 million tax credit, suggesting the company is successfully utilizing R&D tax relief or similar incentives, which is favorable for a firm in engineering and decarbonisation technologies.
  3. Established Operational History: Incorporated in 2010, Catagen has a 15-year track record. The company operates in a highly relevant growth sector (emissions testing and climate technologies) and maintains a workforce of 66 employees, showing operational scale. All statutory filings are up to date with no overdue flags.

4. Due Diligence Notes

  1. Composition of "Other Operating Income": The £3.83 million in other operating income is a massive contributor to gross operating profit. It is critical to determine if this is recurring revenue (e.g., long-term service contracts) or one-off income (e.g., government grants, asset sales, or R&D rebates).
  2. Debt Structure and Covenants: The company has £5.8 million in bank loans (split between short and long-term). An investor must review the terms of these facilities, specifically regarding interest rates, maturity profiles, and any financial covenants. Given the drop in cash, there is a risk of covenant breaches or refinancing difficulties.
  3. Recoverability of Debtors: "Other debtors" increased significantly from £847,730 to £1.72 million. The nature and credit quality of these balances need to be assessed to ensure they are realizable and not tied up in disputed or long-dated contracts.
  4. Asset Valuations: The tangible assets include a £1.38 million revaluation of plant and machinery. The basis of this fair value assessment should be verified, as overvaluation of specialized emissions testing equipment could artificially inflate the net asset base.

Names of the people mentioned are shown to subscribers. See subscription

Perspective: Investment Risk Assessor · Model: glm-5.2 · Generated 6 October 2026